Michael A. Harding

发表

Focal Adhesion Kinase , Rap 1 , and Transcriptional Induction of Vascular Endothelial Growth Factor

M. Conaway, D. Theodorescu, E. Sheta, 2022 .

'Plenty of opal back then: Opal Pulkah': a history of Aboriginal engagement in the Northern South Australian opal industry c.1940–1980

Michael A. Harding, 2016 .

Prognostic Markers in Localized Prostate Cancer: From Microscopes to Molecules

Dan Theodorescu, D. Theodorescu, Michael A. Harding, 1998, Cancer and Metastasis Reviews.

Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways

D. Theodorescu, E. Sheta, Michael A. Harding, 2001, Oncogene.

PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity

C. Moskaluk, H. Frierson, D. Theodorescu, 2004, Oncogene.

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines

D. Theodorescu, Michael A. Harding, D. Welch, 2004, Clinical & Experimental Metastasis.

Invasion and metastasis models for studying RhoGDI2 in bladder cancer.

D. Theodorescu, Michael A. Harding, M. Nitz, 2008, Methods in enzymology.

RhoGDI signaling provides targets for cancer therapy.

D. Theodorescu, Michael A. Harding, 2010, European journal of cancer.

CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

Glen Kristiansen, Dan Theodorescu, H. Frierson, 2012, Cancer research.

RREB1 transcription factor splice variants in urologic cancer.

D. Theodorescu, Michael A. Harding, Steven C. Smith, 2011, The American journal of pathology.

The role of Ral A in epidermal growth factor receptor-regulated cell motility.

D. Theodorescu, Michael A. Harding, J. Gildea, 2002, Cancer research.

CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated

H. Frierson, M. Conaway, D. Theodorescu, 2012, Proceedings of the National Academy of Sciences.

Profiling the Evolution of Human Metastatic Bladder Cancer

H. Frierson, G. Hampton, M. Conaway, 2004, Cancer Research.

Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer

D. Theodorescu, Michael A. Harding, J. Gildea, 2000, Genes, chromosomes & cancer.

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.

C. Moskaluk, H. Frierson, G. Hampton, 2002, Cancer research.

Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling.

K. Arden, D. Theodorescu, Michael A. Harding, 2002, Cancer research.

RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation.

D. Theodorescu, Michael A. Harding, 2007, Urologic oncology.

Localization of overexpressed c-myc mRNA in polycystic kidneys of the cpk mouse.

J. Calvet, V. Gattone, V. Gattone, 1992, Kidney international.

Autosomal-dominant polycystic kidney disease in the rat.

J. Calvet, V. Gattone, V. Gattone, 1993, Kidney international.

Focal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth factor.

M. Conaway, D. Theodorescu, E. Sheta, 2000, Journal of the National Cancer Institute.

The SGP-2 gene is developmentally regulated in the mouse kidney and abnormally expressed in collecting duct cysts in polycystic kidney disease.

J. Calvet, V. Gattone, V. Gattone, 1991, Developmental biology.

Transmembrane motility assay of transiently transfected cells by fluorescent cell counting and luciferase measurement.

D. Theodorescu, Michael A. Harding, J. Gildea, 2000, BioTechniques.

Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.

D. Theodorescu, B. O'dowd, S. George, 2000, Molecular pharmacology.